Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Koios Beverage Corp C.FIT

Alternate Symbol(s):  FITSF

Koios Beverage Corp. is a functional beverage company, which has a distribution network of more than 5,100 retail locations across the United States in which to sell its products. The Company uses a blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Its beverages are offered in various flavors, which include black raspberry, blood orange, peach mango, apricot vanilla, pear guava, and others. It also includes orange cream fit soda, root beer vanilla float fit soda, black cherry fit soda, orange cream fit soda and black cherry cola fit soda, among others. It produces one of the only drinks in the world infused with MCT oil. MCT oil is derived from coconuts. The Company’s supplements include gummy bear flavored nootropic and immunity drink mix stick packs, and gummy bear and blue berry lemonade nootropic and immunity supplement trial stick packs. It has relationships with various distributors in the United States.


CSE:FIT - Post by User

Post by HarryPerkinson Apr 17, 2022 5:51am
153 Views
Post# 34608161

FSD Pharma Inc: Lucid MS Video

FSD Pharma Inc: Lucid MS Video


FSD Pharma is delighted to announce pre-clinical findings indicating the efficacy of Lucid-MS, its flagship medication candidate, in treating Multiple Sclerosis. Lucid-MS's therapeutic potential is an industry first, and we'd like to provide visual evidence of functional recovery in pre-clinical individuals in this video!

<< Previous
Bullboard Posts
Next >>